Supplying medicines to treat a wide range of diseases and conditions
From cholestrol reducers and antibiotics to anti infectives and pain relievers
Focusing on MS, cancer, Parkinson’s, asthma, pain and more
Working hard to bring hope to patients for the future
Millions of patients worldwide have central nervous system disorders, which can have a devastating impact on their quality of life.
Affecting most functions of the body and mind, and often progressively worsening, symptoms of disorders of the central nervous system are treated with many different medicines.
Within our range we have generic and specialty medicines for CNS disorders. These include Copaxone® (glatiramer acetate) injection in 20mg and 40mg for the treatment of multiple sclerosis, and Azilect® (rasagiline) tablets for the treatment of the symptoms of Parkinson’s disease.
Over five million people in the UK are currently receiving treatment for asthma1 and over three million people are living with Chronic Obstructive Pulmonary Disease (COPD).2 Patients typically use reliever and preventer inhalers to manage their symptoms, in devices like pressurised metered dose inhalers (MDIs), breath-activated inhalers (BA MDIs and dry powder inhalers), inhalers with spacer devices or nebulisers.
Within our range of inhalers is DuoResp Spiromax® (budesonide/formoterol fumarate dihydrate) a multi-dose dry-powder inhaler for the management of asthma and COPD and Qvar® (CFC free beclometasone dipropionate). Qvar® is available in Easi-Breathe®, Autohaler® and as a metered dose inhaler for the management of asthma.
Pain relief is a common reason for seeking medical advice. Pain medication is readily available, ranging from what is available in retail stores, to stronger medication available from your pharmacist and on prescription from your GP or specialist.
Around 14 million people in the UK suffer with chronic pain,3 which can have major impact on their quality of life and ability to maintain regular work. Chronic pain sufferers may be prescribed stronger pain relief medication by their doctor or pain specialist.
We have many pain relieving medications in our range of medicines, including those for chronic pain, and what's known as "breakthrough cancer pain" that doctors and other prescribing healthcare professionals can prescribe.
We work hard to ease the way for people with cancer throughout their therapeutic journey and to offer choice and factual scientific based information to Oncology Specialists.
Our medicines treat several types of cancer and associated conditions like neutropenia. (Neutropenia is a low level of neutrophils, a type of white blood cell. All white blood cells help the body fight infection.)
Within Teva's innovative specialty medicines we have Myocet® (liposomal doxorubicin) infusion, Trisenox® (arsenic trioxide) infusion and Lonquex®▼ (lipegfilgrastim) solution for injection.*
We have a range of generic and branded medicines used in the treatment of urological conditions. For the treatment of interstitial cystitis and recurrent bacterial cystitis, Teva markets Cystistat® (hyaluronate sodium) solution, a CE marked class III medical device.
Statistics suggest around one in seven couples may have difficulty conceiving. This is approximately 3.5 million people in the UK. There are many potential causes of infertility, and fertility problems can affect either the man or the woman.5 Regardless of the cause, infertility can be very distressing and put strain upon relationships.
In women’s health, we work hard to improve the quality of care and quality of life for women of all ages worldwide.
We’re doing this with a broad portfolio of solutions in reproductive health, contraception, menopause, and benign gynaecological conditions.
Many of our medicines are generic - generic medicines contain the same active, or key, ingredient(s) as the original medicine brand.
It’s a little bit like buying the premium brand baked beans at the supermarket versus buying the lower cost alternative brand of baked beans from the supermarket themselves. The key ingredient for both is still beans.
We supply more packs of medicine to the NHS each year than anyone else – that's around 13% of total packs of medicine in the UK.6
Generic medicines save the NHS billions of pounds a year.7 These savings mean that when difficult decisions about the allocation of funding need to be made within the NHS, generic medicines have done their part in allowing a proportion of the budget to be freed up.
* This medicine is subject to additional monitoring to allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.
1 http://www.asthma.org.uk/asthma-facts-and-statistics accessed 15.03.16
2 http://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease/Pages/Introduction.aspx accessed 15.03.16
3 http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence#heading-Zero accessed 15.03.16
4 http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence#heading-Zero accessed 15.03.16
5 http://www.nhs.uk/conditions/infertility/pages/introduction.aspx accessed 15.03.16
6 Data on file
7 http://www.britishgenerics.co.uk accessed 15.03.16